Compare NOK & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NOK | ILMN |
|---|---|---|
| Founded | 1865 | 1998 |
| Country | Finland | United States |
| Employees | 78005 | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 74.9B | 19.4B |
| IPO Year | N/A | 2000 |
| Metric | NOK | ILMN |
|---|---|---|
| Price | $13.97 | $142.91 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 17 |
| Target Price | $10.33 | ★ $124.24 |
| AVG Volume (30 Days) | ★ 99.7M | 1.5M |
| Earning Date | 04-23-2026 | 04-30-2026 |
| Dividend Yield | ★ 0.88% | N/A |
| EPS Growth | N/A | ★ 170.87 |
| EPS | N/A | ★ 0.87 |
| Revenue | N/A | ★ $4,343,000,000.00 |
| Revenue This Year | $6.41 | $6.47 |
| Revenue Next Year | $4.10 | $5.58 |
| P/E Ratio | ★ $55.51 | $165.14 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.00 | $78.80 |
| 52 Week High | $15.19 | $155.53 |
| Indicator | NOK | ILMN |
|---|---|---|
| Relative Strength Index (RSI) | 65.02 | 61.90 |
| Support Level | $6.16 | $116.54 |
| Resistance Level | N/A | $153.43 |
| Average True Range (ATR) | 0.82 | 6.07 |
| MACD | 0.08 | 0.85 |
| Stochastic Oscillator | 74.52 | 77.95 |
Nokia is a networking equipment vendor focused primarily on supporting wireless networks and, to a growing extent, Internet Protocol and optical systems. The firm operates three segments. The mobile infrastructure segment sells equipment and software used to operate the core of carrier and enterprise wireless networks. Network infrastructure comprises IP, optical, and fixed-network equipment, including switching and routing equipment, optical components, and devices used in fiber-to-the-premises networks. The portfolio business comprises businesses considered noncore to Nokia in the future, including fixed wireless access customer premises equipment, enterprise campus edge, and microwave radio.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.